Loss of antiphospholipid antibody positivity decreases the risk of recurrent thrombosis in thrombotic antiphospholipid syndrome
The risk of recurrent thrombosis drops significantly after aPL-negativization, highlighting the utility of serial aPL monitoring in clinical practice.
Authors
- Juan Marqués (ORCID: https://orcid.org/0000-0002-9001-8612)
- Vasco C. Romão (ORCID: https://orcid.org/0000-0002-5603-9436)
- Pedro Gaspar (ORCID: https://orcid.org/0000-0002-6965-3435)
- A Abrantes (ORCID: https://orcid.org/0000-0002-1295-9679)
- Filipa Costa (ORCID: https://orcid.org/0009-0007-6713-6091)
- Inês Parreira (ORCID: https://orcid.org/0000-0003-2017-2697)
- João Eurico Fonseca (ORCID: https://orcid.org/0000-0003-1432-3671)
- Ana Rita Cruz-Machado (ORCID: https://orcid.org/0000-0003-0600-876X)
- Joana Martins (ORCID: https://orcid.org/0000-0001-9082-2945)
- Diogo Santos (ORCID: https://orcid.org/0009-0002-4619-6363)
- Ryan Costa Silva (ORCID: https://orcid.org/0000-0002-9208-9043)
- Luís Graça (ORCID: https://orcid.org/0000-0001-6935-8500)
- Ana Teodósio Chícharo (ORCID: https://orcid.org/0009-0005-6867-6036)
- Ana Rita Lopes (ORCID: https://orcid.org/0000-0002-8939-1479)
Institutions
- University of Lisbon (PT)
- Nova Medical (United States) (US)
- Algarve Biomedical Center (PT)
- Hospital de Santa Maria (PT)
- Instituto Gulbenkian de Ciência (PT)
- University of Algarve (PT)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2025-12-11
- DOI
- https://doi.org/10.1093/rheumatology/keaf679
- Citations
- 1
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 1.67
Funders
- Fundação para a Ciência e a Tecnologia